Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

2 deoxy D glucose - Defence Research and Development Organisation/Dr.Reddys Laboratories

Next Previous
Drug Profile

2 deoxy D glucose - Defence Research and Development Organisation/Dr.Reddys Laboratories

Alternative Names: 2-deoxy-D-glucose - Defence Research and Development Organisation/Dr.Reddys Laboratories; 2-DG; 2DG - Defence Research and Development Organisation/Dr.Reddys Laboratories

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Defence Research and Development Organisation
  • Developer Defence Research and Development Organisation; Dr Reddys Laboratories
  • Class Antiepileptic drugs; Antivirals; Deoxy sugars; Small molecules
  • Mechanism of Action Glycolysis inhibitors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed COVID 2019 infections

Most Recent Events

  • 28 Jun 2021 Launched for COVID-2019 infections (Adjunctive treatment) in India (PO)
  • 08 May 2021 Efficacy data from a phase III trial in COVID-2019 infections (Adjunctive treatment) released by Defence Research and Development Organisation
  • 08 May 2021 Safety and efficacy data from a phase II trial in COVID-2019 infections (Adjunctive treatment) released by Defence Research and Development Organisation

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top